Hester Biosciences has informed that it enclosed the transcript of the earnings conference call held by the management of the Company with all the investors over the telephone call on Friday, 30 January 2026 at 2:00 pm (IST) to discuss the financial results for the for the quarter and nine months period ended 31 December 2025.
The above information is a part of company’s filings submitted to BSE.